Paediatric coronavirus vaccine work may begin in India by mid of 2021

Bharat Biotech is testing its whole virus inactivated vaccine, a tech in use for decades, on subjects aged 12 years and above

Paediatric coronavirus, covid, vaccine

According to a UNESCO estimate, around 321 million Indian children were asked to stay home when the lockdown began at the end of March

Sohini Das Mumbai
The pandemic year has turned the conventional way of developing vaccines on its head. Though immunisation worldwide is a paediatric medical event, the first Covid-19 shots developed were for people aged 18 years and above. 

Work on paediatric versions of Covid-19 vaccine, however, is not far behind, according to vaccine manufacturers in the race. A leading vaccine maker, which is in the final leg of developing a Covid-19 vaccine, said: “Once the immunisation programme starts and one can observe the vaccines in use on a mass-scale, the safety of these investigational products would be established beyond doubt. It is around the middle of the next year, that one would plan to start clinical trials for children.”

“Work on paediatric vaccine candidates should

First Published: Dec 21 2020 | 06:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to